Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Synbiobeta

15:33 EDT 19th October 2018 | BioPortfolio

Here are the most relevant search results for "Synbiobeta" found in our extensive news archives from over 250 global news sources.

More Information about Synbiobeta on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Synbiobeta for you to read. Along with our medical data and news we also list Synbiobeta Clinical Trials, which are updated daily. BioPortfolio also has a large database of Synbiobeta Companies for you to search.

Showing News Articles 1–25 of 323 from Synbiobeta

Friday 19th October 2018

The Economist Intelligence Unit and Corteva Agriscience™, Agriculture Division of DowDuPont, Release 2018 Global Food Security Index Findings

Findings signal a shift toward more resilient food security measures. WILMINGTON, Del., Oct. 16, 2018 /PRNewswire/ — Today, Corteva Agriscience™, Agriculture Division of DowDuPont, and The Economist Intelligence Unit (EIU), released the 2018 Global Food Security Index (GFSI) findings. The report, […] The post The Economist Intelligence Unit and Corteva Agriscience™, Agriculture Di...

Thursday 18th October 2018

Oxitec to Develop 2nd Friendly™ Mosquito Strain Designed to Combat Malaria-Spreading Mosquitoes

Expanded collaboration with the Bill & Melinda Gates Foundation will leverage Oxitec’s Friendly™ biological engineering platform to develop a self-limiting Anopheles stephensi strain to help combat malaria in India, Middle East and the Horn of Africa Oxitec’s 2nd generation technology is […] The post Oxitec to Develop 2nd Friendly™ Mosquito Strain Designed to Combat Malaria-Spre...

Tuesday 16th October 2018

Canopy Biosciences Announces Catalog of Genetically Engineered Cell Lines and Lysates

Canopy brings CRISPR technology within the reach of millions of researchers worldwide. Canopy BiosciencesTM, LLC, an established provider of gene editing and personalized medicine technologies, today announced the introduction of a new catalog of over 2000 knockout cell lines and […] The post Canopy Biosciences Announces Catalog of Genetically Engineered Cell Lines and Lysates appeared first...

Monday 15th October 2018

Berkeley Lights Closes $95 Million Funding Round To Expedite Commercial Expansion And Platform Development For Cell Therapy

Financing will also be used to drive R&D and further expand commercial activities for digital cell biology worldwide EMERYVILLE, Calif., Oct. 15, 2018 /PRNewswire/ — Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today the completion of […] The post Berkeley Lights Closes $95 Million Funding Round To Expedite Commercial Expansion And Platform Development F...

Mars Taps Benson Hill’s Crop Design Platform to Help Protect Cacao from Climate Change

Mars will employ CropOS™ to improve the productivity, stress tolerance and climate resilience of cacao trees ST. LOUIS, MO and MCLEAN, VA—October 11, 2018—Benson Hill Biosystems, a crop improvement company unlocking the natural genetic diversity of plants, and Mars, Incorporated, a […] The post Mars Taps Benson Hill’s Crop Design Platform to Help Protect Cacao from Climate Change ap...

Saturday 13th October 2018

Organic farming with gene editing: An oxymoron or a tool for sustainable agriculture?

A University of California, Berkeley professor stands at the front of the room, delivering her invited talk about the potential of genetic engineering. Her audience, full of organic farming advocates, listens uneasily. She notices a man get up from his […] The post Organic farming with gene editing: An oxymoron or a tool for sustainable agriculture? appeared first on SynBioBeta.

Friday 12th October 2018

BioBricks Foundation Announces Publication of OpenMTA in Nature Biotechnology

A new, easy-to-use legal tool enabling open exchange of biological materials is launched. SAN FRANCISCO, Oct. 11, 2018 /PRNewswire/ — The OpenMTA is a Material Transfer Agreement (MTA) designed to support openness, sharing, and innovation in biology and biotechnology. Material Transfer […] The post BioBricks Foundation Announces Publication of OpenMTA in Nature Biotechnology appeared ...

Wednesday 10th October 2018

PerkinElmer Launches Asset Genius™ System for Remote Laboratory Monitoring

Connected system improves research reproducibility and operational efficiency through continuous lab performance monitoring PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its Asset Genius™ system for Laboratory Monitoring, the latest addition […] The post PerkinElmer Launches Asset Genius™ System for Remote Laboratory Monit...

Global Bioenergies reaches 87% of yield target in Isobutene process

Evry (France), 08 October 2018 – Global Bioenergies (Euronext Growth: ALGBE) announces today that a new milestone has been met in the development of its Isobutene process. The company announces a yield exceeding 87% of the final target during the […] The post Global Bioenergies reaches 87% of yield target in Isobutene process appeared first on SynBioBeta.

Tuesday 9th October 2018

A clash of titans: DIY Bio met the homebrew computer club at SynBioBeta 2018

Steve Wozniak: the man who co-founded Apple, a household name. George Church: the synthetic biologist and professor, a mammoth contributor to science, both figuratively and literally. The opening night of SynBioBeta 2018 was the embodiment of technology meeting biology, with […] The post A clash of titans: DIY Bio met the homebrew computer club at SynBioBeta 2018 appeared first on SynBioBeta...

Meet Staph epidermidis, gatekeeper of healthy skin

This story is brought to you by Azitra, a preclinical stage biotechnology company combining the power of the microbiome with cutting-edge genetic engineering to treat skin disease. With all of the talk about CRISPR and genome editing these days, it […] The post Meet Staph epidermidis, gatekeeper of healthy skin appeared first on SynBioBeta.

Thursday 4th October 2018

News Digest #243 – SynBioBeta Day 3, Twist $86.3M IPO, Pivot Bio’s $70M, Genomatica’s $90M

The post News Digest #243 – SynBioBeta Day 3, Twist $86.3M IPO, Pivot Bio’s $70M, Genomatica’s $90M appeared first on SynBioBeta.

Highlights of Day 1 of SynBioBeta 2018: Mushroom stage, The homebrew computer club meets DIYBio, Engineering Biology Awards

Enjoying Synthetic Biology Week? Share your stories with #synbiobeta2018 The conference began with a discussion between P&G Director Lee Ellen Drechsler and Ecovative CEO Eben Bayer, moderated by D.A. Wallach of Inevitable Ventures. The three discussed how biology is being […] The post Highlights of Day 1 of SynBioBeta 2018: Mushroom stage, The homebrew computer club meets DIYBio, Engine...

A Pulitzer Prize for Evolutionary Biology

The Nobel Prize in Chemistry was awarded yesterday to three recipients for discovering methods in controlling and speeding enzyme and antibody evolution. Frances H. Arnold, a professor of chemical engineering at the California Institute of Technology, was awarded one half […] The post A Pulitzer Prize for Evolutionary Biology appeared first on SynBioBeta.

TWB contributes to the development of synthetic biology in France

TWB develops and leads collaborative public/private R&D projects, particularly in the field of synthetic biology. TWB announces the success of the ‘SYNTHACS’ project and the second edition of the event “TWB start-up day – From Biosciences to Bioproduction” on 12 […] The post TWB contributes to the development of synthetic biology in France appeared first on SynBioBeta.

Wednesday 3rd October 2018

Next Generation, Non-GMO Natural Preservatives Developed By Conagen

BEDFORD, Mass., Oct. 3, 2018 /PRNewswire/ — Conagen, an innovative biotechnology company announced today that it had a major breakthrough in developing next-generation natural preservatives through patent-pending technology. This ready-to-go technology will help potential partners with successful commercialization in 2019. Preservatives […] The post Next Generation, Non-GMO Natural Pr...

Highlights of SynBioBeta 2018 Day 3, Twist $86.3M IPO, Pivot Bio’s $70M, Genomatica’s $90M

John Cumbers took the stage to welcome our community and announce that Twist Bioscience filed for a $86.3M IPO! He also mentioned that the Nobel Prize in chemistry was awarded jointly to three scientists whose work contributed to the foundation […] The post Highlights of SynBioBeta 2018 Day 3, Twist $86.3M IPO, Pivot Bio’s $70M, Genomatica’s $90M appeared first on SynBioBeta.

Twist Bioscience Files for $86.3M IPO

Today, Twist Bioscience filed an S-1 with the U.S. Securities and Exchange Commission (SEC), announcing its intent to undergo an initial public offering. The filing shows that Twist intends to raise $86.3 million in funds, though it does not include […] The post Twist Bioscience Files for $86.3M IPO appeared first on SynBioBeta.

Genomatica Completes $90 Million Financing to Drive Technologies for More Sustainable Everyday Products

Accelerates expansion of product lines; strengthens partnership with Ginkgo Bioworks San Diego, CA, October 3, 2018 – Genomatica announced it issued $90 million in its latest equity offering, strengthening its balance sheet to fully execute on its business plan and […] The post Genomatica Completes $90 Million Financing to Drive Technologies for More Sustainable Everyday Products appeared ...

Riffyn launches Open Access for scientists at non-profits

To celebrate the ground-breaking publication of Riffyn SDE in the journal Scientific Data, Riffyn is launching Open Access which provides free use of the SDE for next-generation design and publishing of experiments.  Oakland, CA, USA, 3 October 2018 – Riffyn, […] The post Riffyn launches Open Access for scientists at non-profits appeared first on SynBioBeta.

Tuesday 2nd October 2018

Highlights of SynBioBeta Day 2: Neobiological revolution, bio is not another app, living medicines, and biosecurity

What a jam-packed second day today! We kicked things off with an energizing fireside chat on the coming together of neuroscience and synthetic biology – and the neobiological revolution we’ve all been witnessing in real time. MIT’s Ed Boyden, OS […] The post Highlights of SynBioBeta Day 2: Neobiological revolution, bio is not another app, living medicines, and biosecurity appeared firs...

Bristol-based company breaks records for a UK biodesign exit

Biodesign spinout company Ziylo has been acquired by global healthcare company Novo Nordisk in a deal that could exceed $800M. Ziylo was founded in 2014 by Professor Tony Davis, Dr Harry Destecroix and Tom Smart. Based on University of Bristol […] The post Bristol-based company breaks records for a UK biodesign exit appeared first on SynBioBeta.

Technology Roadmap Poised to Revolutionize Discovery at the Intersection of Semiconductors and Synthetic Biology

NIST Advanced Manufacturing Technology (AMTech) partners with SRC and funds SemiSynBio Roadmap to address advanced manufacturing challenges  Semiconductor Research Corporation (SRC) today announced the release of their much anticipated Semiconductor Synthetic Biology (SemiSynBio) Technology Roadmap. Biological systems are significantly more […] The post Technology Roadmap Poised to Revoluti...

Watch the SynBioBeta 2018 live stream

 The post Watch the SynBioBeta 2018 live stream appeared first on SynBioBeta.

Ecovative Announces MycoFlex TM, the Next-Generation Mycelium Biofabrication Platform

The biomaterials company is launching its newest platform at SynBioBeta 2018; new mycelium platform supports applications in apparel, beauty, food and medtech. Troy, New York, October 2, 2018–Ecovative, the New York-based biomaterials company, today announced the launch of MycoFlexTM, its […] The post Ecovative Announces MycoFlex TM, the Next-Generation Mycelium Biofabrication Platform...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks